查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566966

生物工艺袋市场：按类型、工作流程和最终用户分类：2024-2033 年全球机会分析和产业预测

Bioprocess Bags Market By Type , By Workflow By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年生物工艺袋市场规模为33亿美元，预计2033年将达149亿美元，2024年至2033年复合年增长率为16.4%。

生物工艺袋是由高等级聚合物製成的一次性高性能袋子，可用于生物製药液体的储存、物料输送和运输，包括细胞培养基、介质、缓衝液和其他关键材料。过程应用，例如这些袋子旨在保持无菌并降低交叉污染的风险。由于对可提高效率和更大操作灵活性的一次性技术的需求不断增加，其用途正在迅速扩大。

全球生物加工袋市场的成长主要是由于对疫苗、单株抗体和细胞疗法等生物製药的需求激增，以及由于成本效益和风险降低而越来越多地采用一次性技术的污染。研究表明，与传统不銹钢系统相比，在细胞培养过程中使用生物工艺袋可以将交叉污染的风险降低 90% 以上，因为其一次性使用且无需复杂的清洗程序。此外，与传统的不銹钢系统相比，生物工艺袋可以降低资本和营运成本，例如减少清洗和验证要求，这是全球市场的关键驱动力。此外，与这些袋子相关的多种优势促进了市场的成长。例如，袋子可以在生物製造过程中轻鬆快速地实现可扩展性，这对于满足对生技药品和个人化药物日益增长的需求至关重要。此外，在大流行等全球健康挑战的刺激下，对疫苗和其他生物製药的需求增加了对生物工艺袋进行高效生产和分销的依赖。由于需要减少对环境的影响并提高生物製造过程的整体永续性，该行业正在转向在生物工艺袋中使用永续和环保的材料，预计这将大大促进市场成长。然而，一次性生物加工袋产生大量塑胶废弃物，加上对其环境影响的日益担忧以及对永续处理方法的压力越来越大，正在阻碍市场的成长。此外，与生物处理袋中使用的聚合材料中的可浸出物和萃取物污染产品相关的潜在风险阻碍了生物处理袋的使用。相反，生物工艺袋材料和设计的持续进步，例如改进的阻隔性能和对广泛生物工艺应用的适用性，预计将为预测期内的市场成长提供有利的机会。此外，製造商也致力于提高生物製程袋的无菌性并维持产品完整性，这满足了高价值生技药品无污染生产的迫切需求。此类新兴市场的开拓预计将为市场成长开闢新的途径。

全球生物工艺袋产业按类型、工作流程、最终用户和地区细分。按类型划分，市场分为 2D 生物工艺袋、3D 生物工艺袋等。依工作流程可分为上游工程、下游流程、流程开发。依最终用户分为製药/生物製药公司、CMO/CRO、学术/研究机构。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，预计 2D 生物工艺袋细分市场将在 2024 年至 2033 年期间占据市场主导地位。

根据工作流程，上游工程部分预计将在预测期内呈现最高成长。

从最终用户来看，製药和生物技术公司预计将在未来几年成为主导领域。

按地区划分，就 2023 年以收益为准，北美占据最大市场占有率，预计在预测期内也将主导市场。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 根据客户兴趣加入公司简介
  • 扩大公司简介列表

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章生物工艺袋市场：依类型

  • 市场概况
  • 2D生物工艺袋
  • 3D生物工艺袋
  • 其他的

第五章生物工艺袋市场：依工作流程

  • 市场概况
  • 上游工程
  • 下游工艺
  • 製程开发

第六章生物工艺袋市场：依最终用户分类

  • 市场概况
  • 製药和生物製药公司
  • 首席行销长和首席研究官
  • 学术/研究机构

第七章生物工艺袋市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国生物工艺袋市场
    • 加拿大生物工艺袋市场
    • 墨西哥生物工艺袋市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国生物工艺袋市场
    • 德国生物工艺袋市场
    • 义大利生物工艺袋市场
    • 西班牙生物工艺袋市场
    • 英国生物工艺袋市场
    • 其他欧洲生物工艺袋市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国生物工艺袋市场
    • 日本生物工艺袋市场
    • 印度生物工艺袋市场
    • 韩国生物工艺袋市场
    • 澳洲生物工艺袋市场
    • 其他亚太地区生物工艺袋市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西生物工艺袋市场
    • 南非生物工艺袋市场
    • 沙乌地阿拉伯生物工艺袋市场
    • 其他拉丁美洲/中东/非洲生物工艺袋市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation
  • Saint-Gobain Performance Plastics.
  • Lonza Group AG
  • Eppendorf AG
  • Meissner Filtration Products, Inc.
  • PBS Biotech, Inc.
  • GE Healthcare
简介目录
Product Code: A324380

The bioprocess bags market was valued at $3.3 billion in 2023, and is projected to reach $14.9 billion by 2033, growing at a CAGR of 16.4% from 2024 to 2033.

Bioprocess bag is a single-use, high-performance bag that is made from high-grade polymers, making it compatible for a wide range of bioprocessing applications such as storage, handling, and transportation of biopharmaceutical fluids, including cell cultures, media, buffers, and other critical materials. These bags are designed to maintain the sterility and reduce the risk of cross-contamination. Their use is rapidly expanding due to the growing demand for single-use technologies, which offer increased efficiency and superior operational flexibility.

The growth of the global bioprocess bags market is majorly driven by surge in demand for biopharmaceuticals, such as vaccines, monoclonal antibodies, and cell therapies as well as increase in adoption of single-use technologies due to their cost-effectiveness and reduced risk of contamination. Studies have shown that the use of bioprocess bags in cell culture processes can reduce the risk of cross-contamination by over 90% compared to traditional stainless steel systems, due to their single-use nature and elimination of complex cleaning procedures. Furthermore, bioprocess bags offer lower capital and operational costs compared to traditional stainless steel systems, including reduced cleaning and validation requirements, which acts as a key driving force of the global market. Moreover, multiple benefits associated with these bags augment the market growth; for instance, they allow for easy and quick scalability in biomanufacturing processes, which is crucial in meeting the growing demand for biologics and personalized medicines. In addition, the demand for vaccines and other biopharmaceutical products, spurred by global health challenges like pandemics, has increased the reliance on bioprocess bags for efficient production and distribution. The industry is shifting toward the use of sustainable and eco-friendly materials for bioprocess bags, driven by the need to reduce environmental impact and improve the overall sustainability of biomanufacturing processes, which is expected to notably contribute toward the market growth. However, generation of generates a significant amount of plastic waste due to single-use bioprocess bags coupled with rise in concerns about environmental impact and increase in pressure for sustainable disposal methods hamper the market growth. Moreover, potential risk associated with contamination of products due to leachable and extractables from the polymer materials used in bioprocess bags restrain the use of bioprocess bags. On the contrary, continuous advancements in the materials and design of bioprocess bags, such as improved barrier properties and compatibility with a broader range of bioprocessing applications, are expected to offer lucrative opportunities for the market growth during the forecast period. In addition, manufacturers are focusing on improving sterility and maintaining product integrity of bioprocess bags, which will address the critical need for contamination-free production in high-value biologics. Such developments are anticipated to open new avenues for the market growth.

The global bioprocess bags industry is segmented into type, workflow, end user, and region. On the basis of type, the market is bifurcated into 2D bioprocess bags, 3D bioprocess bags, and others. By workflow, it is divided into upstream process, downstream process, and process development. Depending on end user, it is segregated into pharmaceutical & biopharmaceutical companies, CMOs & CROs, and academic & research institute. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the 2D bioprocess bags segment is expected to dominate the market from 2024 to 2033.

On the basis of workflow, the upstream process segment is anticipated to exhibit the highest growth during the forecast period.

Depending on end user, pharmaceutical & biotechnology companies is projected to emerge as the leading segment in the coming years.

Region wise, North America held the largest market share, in terms of revenue, in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bioprocess bags market include Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Saint-Gobain Performance Plastics., Lonza Group AG, Eppendorf AG, Meissner Filtration Products, Inc., PBS Biotech, Inc., and GE Healthcare. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles

Key Market Segments

By Type

  • 2D bioprocess bags
  • 3D bioprocess bags
  • Others

By Workflow

  • Upstream Process
  • Downstream Process
  • Process Development

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • CMOs and CROs
  • Academic and Research Institute

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Merck KGaA
    • Danaher Corporation
    • Saint-Gobain Performance Plastics.
    • Lonza Group AG
    • Eppendorf AG
    • Meissner Filtration Products, Inc.
    • PBS Biotech, Inc.
    • GE Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOPROCESS BAGS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. 2D Bioprocess Bags
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. 3D Bioprocess Bags
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOPROCESS BAGS MARKET, BY WORKFLOW

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Workflow
  • 5.2. Upstream Process
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Downstream Process
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Process Development
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: BIOPROCESS BAGS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Pharmaceutical And Biopharmaceutical Companies
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. CMOs And CROs
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Academic And Research Institute
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BIOPROCESS BAGS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Workflow
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Bioprocess Bags Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Workflow
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Bioprocess Bags Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Workflow
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Bioprocess Bags Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Workflow
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Workflow
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Bioprocess Bags Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Workflow
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Bioprocess Bags Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Workflow
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Bioprocess Bags Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Workflow
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Bioprocess Bags Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Workflow
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Bioprocess Bags Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Workflow
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Bioprocess Bags Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Workflow
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Workflow
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Bioprocess Bags Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Workflow
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Bioprocess Bags Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Workflow
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Bioprocess Bags Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Workflow
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Bioprocess Bags Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Workflow
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Bioprocess Bags Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Workflow
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Bioprocess Bags Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Workflow
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Workflow
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Bioprocess Bags Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Workflow
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Bioprocess Bags Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Workflow
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Bioprocess Bags Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Workflow
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Bioprocess Bags Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Workflow
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Thermo Fisher Scientific Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Sartorius AG
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Merck KGaA
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Danaher Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Saint-Gobain Performance Plastics.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Lonza Group AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Eppendorf AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Meissner Filtration Products, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PBS Biotech, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. GE Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments